-+ 0.00%
-+ 0.00%
-+ 0.00%

TERNS PHARMACEUTICALS INC : LEERINK PARTNERS CUTS TO MARKET PERFORM FROM OUTPERFORM; CUTS TARGET PRICE TO $53 FROM $58

Reuters·04/08/2026 13:33:08

Please log in to view news